Clinical Trial Update: Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is investigating the effects of psilocybin in patients with amyotrophic lateral sclerosis, and the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Amyotrophic Lateral Sclerosis | EARLY_Phase 1 | Status: RECRUITING